Kamishoyosan reduces anxiety-like behavior by modulating GABAA receptor subunit expression in a premenstrual syndrome rat model
IntroductionPremenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) involve psychological symptoms that impact women’s quality of life. PMS pathogenesis is characterized by fluctuations in steroid hormones and γ-aminobutyric acid type A receptor (GABAAR) subunits. Kamishoyosan (KSS) is a Kampo medicine typically used to treat menstrual-related symptoms. This study aimed to…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
Breaking Our Karmic Links
United States
-
My Journey to Mindfulness
United States
-
20 Things 90 Years of Wisdom Encouraged Me to Stop Worrying About
United States
-
Remote supervised exercise- and physical activity-based rehabilitation for post-stroke depression, anxiety, and quality of life: a systematic review, evidence map, and exploratory quantitative synthesis
Switzerland
-
Resilience and clinical recovery in first-episode schizophrenia: a 10-year longitudinal study of clinically recovered, non-recovered, and healthy control participants
Switzerland
-
Context presentation and native conversation structure in large language model responses to escalating suicide risk: a controlled multimodel evaluation
Switzerland
-
Case Report: Electroencephalography-informed low-frequency repetitive transcranial magnetic stimulation targeting the supplementary motor area in severe functional movement disorder
Switzerland
-
Anxiety and depressive symptoms and health-related quality of life in girls with central precocious puberty versus isolated premature thelarche: a comparative cross-sectional study
Switzerland